Joachim Burman

Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis

Sreenivasan, Akshai Parakkal; Vaivade, Aina; Noui, Yassine; Emami Khoonsari, Payam et al.

Ingår i npj Digital Medicine, 2025

• DOI för Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis
• Ladda ner fulltext (pdf) av Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis

Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening

Erngren, Ida; Vaivade, Aina; Carlsson, Henrik; Al-Grety, Asma et al.

Ingår i BMC Medicine, 2025

• DOI för Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening
• Ladda ner fulltext (pdf) av Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening

Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Vaivade, Aina; Erngren, Ida; Carlsson, Henrik; Freyhult, Eva et al.

Ingår i Nature Communications, 2025

• DOI för Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening
• Ladda ner fulltext (pdf) av Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Kosek, Sonja; Kilsved, Ellen; Danfors, Torsten; Cunningham, Janet L et al.

Ingår i Clinical Nuclear Medicine, s. 208-213, 2025

• DOI för Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation

Aulin, Julia; Sjölin, Karl; Lindbäck, Johan; Benz, Alexander P. et al.

Ingår i Journal of the American Heart Association, 2025

• DOI för Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
• Ladda ner fulltext (pdf) av Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation

Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis

Sreenivasan, Akshai Parakkal; Vaivade, Aina; Noui, Yassine; Emami Khoonsari, Payam et al.

Ingår i npj Digital Medicine, 2025

• DOI för Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis
• Ladda ner fulltext (pdf) av Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis

Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening

Erngren, Ida; Vaivade, Aina; Carlsson, Henrik; Al-Grety, Asma et al.

Ingår i BMC Medicine, 2025

• DOI för Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening
• Ladda ner fulltext (pdf) av Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening

Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Vaivade, Aina; Erngren, Ida; Carlsson, Henrik; Freyhult, Eva et al.

Ingår i Nature Communications, 2025

• DOI för Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening
• Ladda ner fulltext (pdf) av Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening

Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Kosek, Sonja; Kilsved, Ellen; Danfors, Torsten; Cunningham, Janet L et al.

Ingår i Clinical Nuclear Medicine, s. 208-213, 2025

• DOI för Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.

Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation

Aulin, Julia; Sjölin, Karl; Lindbäck, Johan; Benz, Alexander P. et al.

Ingår i Journal of the American Heart Association, 2025

• DOI för Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation
• Ladda ner fulltext (pdf) av Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation Not Receiving Oral Anticoagulation

Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Pavlovic, Ivan; Axling, Fredrik; Hayat Nazir, Faisal; Müller, Malin et al.

Ingår i Neurology, 2025

• DOI för Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
• Ladda ner fulltext (pdf) av Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation

Aulin, Julia; Sjölin, Karl; Lindbäck, Johan; Benz, Alexander P et al.

Ingår i Circulation, s. 1090-1100, 2024

• DOI för Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation

Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder: Can immune tolerance be reestablished?

Burt, Richard K; Burman, Joachim; Greco, Raffaella; Rose, John W

Ingår i Handbook of Clinical Neurology, s. 169-197, 2024

• DOI för Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder: Can immune tolerance be reestablished?

Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?

Burt, Richard K; Burman, Joachim; Barker, Alexander; Sharrack, Basil

Ingår i Handbook of Clinical Neurology, s. 199-238, 2024

• DOI för Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab

Piehl, Fredrik; Alping, Peter; Virtanen, Suvi; Englund, Simon et al.

Ingår i Annals of Neurology, s. 678-693, 2024

• DOI för COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
• Ladda ner fulltext (pdf) av COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

Silfverberg, Thomas; Zjukovskaja, Christina; Noui, Yassine; Carlson, Kristina et al.

Ingår i Bone Marrow Transplantation, s. 1601-1610, 2024

• DOI för BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis
• Ladda ner fulltext (pdf) av BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Syk, Mikaela; Tornvind, Emma; Gallwitz, Maike; Fällmar, David et al.

Ingår i Translational Psychiatry, 2024

• DOI för An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease
• Ladda ner fulltext (pdf) av An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease

Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series

Kosek, Sonja; Burman, Joachim; Rostedt Punga, Anna

Ingår i Brain and Behavior, 2024

• DOI för Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series
• Ladda ner fulltext (pdf) av Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series

Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis

Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Massey, Jennifer et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 775-783, 2024

• DOI för Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis

Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study

Tolf, Andreas; Gauffin, Helena; Burman, Joachim; Landtblom, Anne-Marie et al.

Ingår i PLOS ONE, 2024

• DOI för Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study
• Ladda ner fulltext (pdf) av Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study

Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population

Tigchelaar, Celien; Cunningham, Janet L.; Rasmusson, Annica J.; Thulin, Måns et al.

Ingår i iScience, 2024

• DOI för Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population
• Ladda ner fulltext (pdf) av Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Longinetti, Elisa; Englund, Simon; Burman, Joachim; Fink, Katharina et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 134-141, 2024

• DOI för Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
• Ladda ner fulltext (pdf) av Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 125-133, 2024

• DOI för Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Ladda ner fulltext (pdf) av Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

Greco, Raffaella; Alexander, Tobias; Del Papa, Nicoletta; Mueller, Fabian et al.

Ingår i eClinicalMedicine, 2024

• DOI för Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
• Ladda ner fulltext (pdf) av Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation

Pavlovic, Ivan; Zjukovskaja, Christina; Hayat Nazir, Faisal; Müller, Malin et al.

Ingår i Multiple Sclerosis and Related Disorders, 2024

• DOI för Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation
• Ladda ner fulltext (pdf) av Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation

Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis

Katsarogiannis, Evangelos; Axelson, Hans; Berntsson, Shala; Rothkegel, Holger et al.

Ingår i Multiple Sclerosis and Related Disorders, 2024

• DOI för Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis

Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines

Nazir, Faisal Hayat; Wiberg, Anna; Müller, Malin; Mangsbo, Sara et al.

Ingår i Brain Communications, 2023

• DOI för Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines
• Ladda ner fulltext (pdf) av Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines

Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zafeiri, Lida; Åkerfeldt, Torbjörn; Tolf, Andreas; Carlson, Kristina et al.

Ingår i PLOS ONE, 2023

• DOI för Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation

Sjölin, Karl; Christersson, Christina; James, Stefan; Lindbäck, Johan et al.

Ingår i Cardiology, s. 478-483, 2023

• DOI för Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation
• Ladda ner fulltext (pdf) av Plasma neurofilament light chain is elevated after transcatheter aortic valve implantation

Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

Kosek, Sonja; Persson, Barbro; Rodrigues, Rui; Malmestrom, Clas et al.

Ingår i Acta Neurologica Scandinavica, 2023

• DOI för Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden
• Ladda ner fulltext (pdf) av Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

Experiences in implementing immunopsychiatry in real life

Cunningham, Janet L.; Nordmark, Gunnel; Fällmar, David; Cervenka, Simon et al.

Ingår i Journal of Affective Disorders Reports, 2023

• DOI för Experiences in implementing immunopsychiatry in real life
• Ladda ner fulltext (pdf) av Experiences in implementing immunopsychiatry in real life

Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Lundblad, Katarina; Zjukovskaja, Christina; Larsson, Anders; Cherif, Honar et al.

Ingår i Neurology, 2023

• DOI för Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Cerebrospinal fluid concentrations of CXCL13 and sCD27 are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Disease phenotype prediction in multiple sclerosis

Herman, Stephanie; Arvidsson McShane, Staffan; Zhukovsky, Christina; Emami, Payam et al.

Ingår i iScience, 2023

• DOI för Disease phenotype prediction in multiple sclerosis
• Ladda ner fulltext (pdf) av Disease phenotype prediction in multiple sclerosis

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Braun, Madelen; Boström, Gustaf; Ingelsson, Martin; Kilander, Lena et al.

Ingår i Fluids and Barriers of the CNS, 2023

• DOI för Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
• Ladda ner fulltext (pdf) av Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort

Englund, Simon; Kierkegaard, Marie; Burman, Joachim; Fink, Katharina et al.

Ingår i Multiple Sclerosis and Related Disorders, 2023

• DOI för Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Freedman, Mark S. et al.

Ingår i JAMA Neurology, s. 702-713, 2023

• DOI för Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Vaivade, Aina; Wiberg, Anna; Khoonsari, Payam Emami; Carlsson, Henrik et al.

Ingår i Lipids in Health and Disease, 2023

• DOI för Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
• Ladda ner fulltext (pdf) av Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction

Young, Peter; Appel, Lieuwe; Tolf, Andreas; Kosmidis, Savvas et al.

Ingår i EJNMMI Physics, 2023

• DOI för Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction
• Ladda ner fulltext (pdf) av Image-derived input functions from dynamic O-15-water PET scans using penalised reconstruction

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis

Burman, Joachim; Zhukovskaja, Christina; Svenningsson, Anders; Freyhult, Eva et al.

Ingår i Brain Communications, 2023

• DOI för Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
• Ladda ner fulltext (pdf) av Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis

COVID-19 clinical outcomes and DMT of MS patients and population-based controls

Longinetti, Elisa; Bower, Hannah; McKay, Kyla A.; Englund, Simon et al.

Ingår i Annals of Clinical and Translational Neurology, s. 1449-1458, 2022

• DOI för COVID-19 clinical outcomes and DMT of MS patients and population-based controls
• Ladda ner fulltext (pdf) av COVID-19 clinical outcomes and DMT of MS patients and population-based controls

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Sjölin, Karl; Aulin, Julia; Wallentin, Lars; Eriksson, Niclas et al.

Ingår i Journal of the American Heart Association, 2022

• DOI för Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
• Ladda ner fulltext (pdf) av Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Temporal trends of epilepsy in multiple sclerosis

Mahamud, Zamzam; Burman, Joachim; Zelano, Johan

Ingår i Acta Neurologica Scandinavica, s. 492-498, 2022

• DOI för Temporal trends of epilepsy in multiple sclerosis
• Ladda ner fulltext (pdf) av Temporal trends of epilepsy in multiple sclerosis

Distribution of five clinically important neuroglial proteins in the human brain.

Sjölin, Karl; Kultima, Kim; larsson, Anders; Freyhult, Eva et al.

Ingår i Molecular brain, 2022

• DOI för Distribution of five clinically important neuroglial proteins in the human brain.
• Ladda ner fulltext (pdf) av Distribution of five clinically important neuroglial proteins in the human brain.

Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT

Kvistad, Silje Agnethe Stokke; Burman, Joachim; Lehmann, Anne Kristine; Tolf, Andreas et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 844-848, 2022

• DOI för Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
• Ladda ner fulltext (pdf) av Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT

Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Tolf, Andreas; Wiberg, Anna; Müller, Malin; Nazir, Faisal Hayat et al.

Ingår i JAMA Network Open, 2022

• DOI för Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
• Ladda ner fulltext (pdf) av Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

Lauren, Ida; Havervall, Sebastian; Ng, Henry; Lord, Martin et al.

Ingår i Immunity, Inflammation and Disease, 2022

• DOI för Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
• Ladda ner fulltext (pdf) av Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology

Evaluation of polarity switching for untargeted lipidomics using liquid chromatography coupled to high resolution mass spectrometry

Carlsson, Henrik; Vaivade, Aina; Emami Khoonsari, Payam; Burman, Joachim et al.

Ingår i Journal of chromatography. B, 2022

• DOI för Evaluation of polarity switching for untargeted lipidomics using liquid chromatography coupled to high resolution mass spectrometry
• Ladda ner fulltext (pdf) av Evaluation of polarity switching for untargeted lipidomics using liquid chromatography coupled to high resolution mass spectrometry

Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zhukovsky, Christina; Larsson, Anders; Cherif, Honar; Kultima, Kim et al.

Ingår i Multiple Sclerosis and Related Disorders, 2022

• DOI för Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Ladda ner fulltext (pdf) av Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis

Tedeholm, H.; Piehl, F.; Lycke, J.; Link, J. et al.

Ingår i Multiple Sclerosis and Related Disorders, 2022

• DOI för Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
• Ladda ner fulltext (pdf) av Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Svenningsson, Anders; Frisell, Thomas; Burman, Joachim; Salzer, Jonatan et al.

Ingår i Lancet Neurology, s. 693-703, 2022

• DOI för Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

Alexander, Tobias; Snowden, John A.; Burman, Joachim; Chang, Hyun-Dong et al.

Ingår i Frontiers in Oncology, 2021

• DOI för Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT
• Ladda ner fulltext (pdf) av Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing

Carlsson, Henrik; Rollborn, Niclas; Herman, Stephanie; Freyhult, Eva et al.

Ingår i Metabolites, 2021

• DOI för Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
• Ladda ner fulltext (pdf) av Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing

Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

Alping, Peter; Burman, Joachim; Lycke, Jan; Frisell, Thomas et al.

Ingår i Neurology, 2021

• DOI för Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis
• Ladda ner fulltext (pdf) av Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

Delaying the inevitable: Are disease modifying drugs for progressive MS worthwhile?

Burman, Joachim

Ingår i Multiple Sclerosis and Related Disorders, 2021

• DOI för Delaying the inevitable: Are disease modifying drugs for progressive MS worthwhile?

Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study

Mahamud, Zamzam; Hakansson, Samuel; Burman, Joachim; Zelano, Johan

Ingår i Epilepsy & Behavior, 2021

• DOI för Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study
• Ladda ner fulltext (pdf) av Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Greco, Raffaella; Alexander, Tobias; Burman, Joachim; Del Papa, Nicoletta et al.

Ingår i Bone Marrow Transplantation, s. 1493-1508, 2021

• DOI för Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
• Ladda ner fulltext (pdf) av Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 189-194, 2021

• DOI för Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
• Ladda ner fulltext (pdf) av Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-β treatment

Zhukovsky, Christina; Herman, Stephanie; Wiberg, Anna; Cunningham, Janet et al.

Ingår i Acta Neurologica Scandinavica, s. 602-607, 2021

• DOI för Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-β treatment
• Ladda ner fulltext (pdf) av Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-β treatment

Cerebral blood flow measurements with ¹⁵O-water PET using a non-invasive machine-learning-derived arterial input function

Kuttner, Samuel; Wickstrøm, Kristoffer Knutsen; Lubberink, Mark; Tolf, Andreas et al.

Ingår i Journal of Cerebral Blood Flow and Metabolism, s. 2229-2241, 2021

• DOI för Cerebral blood flow measurements with ¹⁵O-water PET using a non-invasive machine-learning-derived arterial input function
• Ladda ner fulltext (pdf) av Cerebral blood flow measurements with ¹⁵O-water PET using a non-invasive machine-learning-derived arterial input function

Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension

Bergman, Joakim; Burman, Joachim; Bergenheim, Tommy; Svenningsson, Anders

Ingår i Journal of Neurology, s. 651-657, 2021

• DOI för Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
• Ladda ner fulltext (pdf) av Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension

Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid

Peters, Kristian; Herman, Stephanie; Emami Khoonsari, Payam; Burman, Joachim et al.

Ingår i Scientific Reports, 2021

• DOI för Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid
• Ladda ner fulltext (pdf) av Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Niemelä, Valter; Landtblom, Anne-Marie; Nyholm, Dag; Kneider, Maria et al.

Ingår i Movement Disorders, s. 481-491, 2021

• DOI för Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
• Ladda ner fulltext (pdf) av Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis

Das, J.; Snowden, J. A.; Burman, Joachim; Freedman, M. S. et al.

Ingår i Multiple Sclerosis Journal, s. 1198-1204, 2021

• DOI för Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis
• Ladda ner fulltext (pdf) av Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis

Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Bergman, Joakim; Svenningsson, Anders; Liv, Per; Bergenheim, Tommy et al.

Ingår i Fluids and Barriers of the CNS, 2020

• DOI för Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
• Ladda ner fulltext (pdf) av Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Larsson, Diane; Åkerfeldt, Torbjörn; Carlson, Kristina; Burman, Joachim

Ingår i Multiple Sclerosis Journal, s. 1351-1359, 2020

• DOI för Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS

Granqvist, Mathias; Burman, Joachim; Gunnarsson, Martin; Lycke, Jan et al.

Ingår i Multiple Sclerosis Journal, s. 1532-1539, 2020

• DOI för Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

Sharrack, Basil; Saccardi, Riccardo; Alexander, Tobias; Badoglio, Manuela et al.

Ingår i Bone Marrow Transplantation, s. 283-306, 2020

• DOI för Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
• Ladda ner fulltext (pdf) av Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

Tappenden, P.; Wang, Y.; Sharrack, B.; Burman, Joachim et al.

Ingår i Bone Marrow Transplantation, s. 1473-1475, 2020

• DOI för Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Alping, Peter; Askling, Johan; Burman, Joachim; Fink, Katharina et al.

Ingår i Annals of Neurology, s. 688-699, 2020

• DOI för Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
• Ladda ner fulltext (pdf) av Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Prognostic impact of epilepsy in multiple sclerosis

Mahamud, Zamzam; Burman, Joachim; Zelano, Johan

Ingår i Multiple Sclerosis and Related Disorders, 2020

• DOI för Prognostic impact of epilepsy in multiple sclerosis

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Luna, Gustavo; Alping, Peter; Burman, Joachim; Fink, Katharina et al.

Ingår i JAMA Neurology, s. 184-191, 2020

• DOI för Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry

Carlsson, Henrik; Abujrais, Sandy; Herman, Stephanie; Emami Khoonsari, Payam et al.

Ingår i Metabolomics, 2020

• DOI för Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
• Ladda ner fulltext (pdf) av Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry

Profound but Transient Changes in the Inflammatory Milieu of the Blood During Autologous Hematopoietic Stem Cell Transplantation

Wiberg, Anna; Strömberg, Ulla Ohlsson; Herman, Stephanie; Kultima, Kim et al.

Ingår i Biology of blood and marrow transplantation, s. 50-57, 2020

• DOI för Profound but Transient Changes in the Inflammatory Milieu of the Blood During Autologous Hematopoietic Stem Cell Transplantation

Container-based bioinformatics with Pachyderm

Novella, Jon Ander; Emami Khoonsari, Payam; Herman, Stephanie; Whitenack, Daniel et al.

Ingår i Bioinformatics, s. 839-846, 2019

• DOI för Container-based bioinformatics with Pachyderm

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Tolf, Andreas; Fagius, Jan; Carlson, Kristina; Åkerfeldt, Torbjörn et al.

Ingår i Acta Neurologica Scandinavica, s. 320-327, 2019

• DOI för Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects

Herman, Stephanie; Niemelä, Valter; Emami Khoonsari, Payam; Sundblom, Jimmy et al.

Ingår i Scientific Reports, 2019

• DOI för Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects
• Ladda ner fulltext (pdf) av Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects

Interoperable and scalable data analysis with microservices: Applications in metabolomics

Emami Khoonsari, Payam; Moreno, Pablo; Bergmann, Sven; Burman, Joachim et al.

Ingår i Bioinformatics, s. 3752-3760, 2019

• DOI för Interoperable and scalable data analysis with microservices: Applications in metabolomics
• Ladda ner fulltext (pdf) av Interoperable and scalable data analysis with microservices: Applications in metabolomics

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis

Herman, Stephanie; Åkerfeldt, Torbjörn; Spjuth, Ola; Burman, Joachim et al.

Ingår i Cells, 2019

• DOI för Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
• Ladda ner fulltext (pdf) av Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis

Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease

Feresiadou, Amalia; Nilsson, Kenneth; Ingelsson, Martin; Press, Rayomand et al.

Ingår i Journal of Neuroimmunology, s. 31-36, 2019

• DOI för Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations

Alping, Peter; Piehl, Fredrik; Langer-Gould, Annette; Frisell, Thomas et al.

Ingår i Epidemiology, s. 230-233, 2019

• DOI för Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
• Ladda ner fulltext (pdf) av Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Burt, Richard K.; Balabanov, Roumen; Burman, Joachim; Sharrack, Basil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 165-174, 2019

• DOI för Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.

Herman, Stephanie; Emami Khoonsari, Payam; Tolf, Andreas; Steinmetz, Julia et al.

Ingår i Theranostics, s. 4477-4490, 2018

• DOI för Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.
• Ladda ner fulltext (pdf) av Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4)

Demirbuker, S. Safer; Kågström, S.; Fält, A.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 922-923, 2018

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Kagström, S.; Fält, A.; Demirbuker, S. Safer; Berglund, A. et al.

Ingår i Multiple Sclerosis Journal, s. 699-700, 2018

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)

Fält, A.; Kagstrom, S.; Demirbuker, S. Safer; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 696-697, 2018

Real-world longitudinal data of peginterferon beta-1a from a Swedish national post-marketing surveillance study (IMSE 6) - efficacy and safety profile

Kågström, S.; Fält, A.; Demirbuker, S. Safer; Berglund, A. et al.

Ingår i Multiple Sclerosis Journal, s. 927-928, 2018

The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis.

Das, J.; Snowden, J.; Burman, Joachim; Freedman, M. et al.

Ingår i Multiple Sclerosis Journal, s. 87-88, 2018

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

Demirbuker, S. Safer; Kagström, S.; Fält, A.; Berglund, A. et al.

Ingår i Multiple Sclerosis Journal, s. 701-702, 2018

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

Fält, A.; Kågström, S.; Demirbuker, S. Safer; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 706-707, 2018

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease

Niemelä, Valter; Burman, Joachim; Blennow, Kaj; Zetterberg, Henrik et al.

Ingår i PLOS ONE, 2018

• DOI för Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease
• Ladda ner fulltext (pdf) av Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease

Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS): interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial

Burt, Richard K.; Balabanov, Roumen; Snowden, John A.; Sharrack, Basil et al.

Ingår i Neurology, 2018

Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study

Bergman, Joakim; Burman, Joachim; Gilthorpe, Jonathan D.; Zetterberg, Henrik et al.

Ingår i Neurology, 2018

• DOI för Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden: Outlier or predecessor?

Berntsson, Shala G.; Kristoffersson, A; Boström, I; Feresiadou, Amalia et al.

Ingår i Acta Neurologica Scandinavica, s. 327-331, 2018

• DOI för Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden: Outlier or predecessor?

Treatment of epilepsy in multiple sclerosis

Dagiasi, Loanna; Vall, Victor; Kumlien, Eva; Burman, Joachim et al.

Ingår i Seizure, s. 47-51, 2018

• DOI för Treatment of epilepsy in multiple sclerosis

Risk of epilepsy after a single seizure in multiple sclerosis

Mahamud, Z.; Burman, Joachim; Zelano, J.

Ingår i European Journal of Neurology, s. 854-860, 2018

• DOI för Risk of epilepsy after a single seizure in multiple sclerosis

Blogs cannot separate wheat from chaff

Burt, Richard K.; Snowden, John A.; Burman, Joachim; Oliveira, Maria Carolina et al.

Ingår i Science, s. 602-602, 2017

• DOI för Blogs cannot separate wheat from chaff

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Kagstrom, S.; Leandersson, A.; Forsberg, L.; Berglund, A. et al.

Ingår i Multiple Sclerosis Journal, s. 365-366, 2017

Baseline characteristics from the COMBAT-MS study: Initial analyses suggest main driver for therapy choice is geographic location

Alping, P.; Burman, Joachim; Fink, K.; Gunnarsson, M. et al.

Ingår i Multiple Sclerosis Journal, s. 714-714, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4)

Forsberg, L.; Leandersson, A.; Kagstrom, S.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 635-636, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

Forsberg, L.; Kagstrom, S.; Leandersson, A.; Berglund, A. et al.

Ingår i Multiple Sclerosis Journal, s. 884-885, 2017

The diagnosis of OCB-negative MS-patients - an inventory of the Swedish MS register in Uppsala, Sweden

Landtblom, Anne-Marie; Kristoffersson, A.; Jansson, L.; Burman, Joachim et al.

Ingår i Multiple Sclerosis Journal, s. 439-439, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)

Leandersson, A.; Kagstrom, S.; Forsberg, L.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 888-889, 2017

Corpus callosum atrophy in MS is halted by autologous haematopoietic stem cell transplantation

Tolf, Andreas; Granberg, T.; Larsson, Elna-Marie; Landtblom, Anne-Marie et al.

Ingår i Multiple Sclerosis Journal, s. 1006-1007, 2017

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)

Leandersson, A.; Kagstrom, S.; Forsberg, L.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 374-375, 2017

Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

Pauzuolis, Mindaugas; Eich, Torsten; Burman, Joachim

Ingår i PLOS ONE, 2017

• DOI för Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment
• Ladda ner fulltext (pdf) av Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

Snowden, John A.; Badoglio, Manuela; Labopin, Myriam; Giebel, Sebastian et al.

Ingår i Blood Advances, s. 2742-2755, 2017

• DOI för Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Burman, Joachim; Kirgizov, K; Carlson, Kristina; Badoglio, M et al.

Ingår i Bone Marrow Transplantation, s. 1133-1137, 2017

• DOI för Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients: First line drugs vs natalizumab

Fagius, Jan; Feresiadou, Amalia; Larsson, Elna-Marie; Burman, Joachim

Ingår i Multiple Sclerosis and Related Disorders, s. 82-87, 2017

• DOI för Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients: First line drugs vs natalizumab

Inflammatory immune response after autologous transplantation in neurologic diseases

Innocenti, C.; Burman, Joachim; Burns, C.; Burt, R.

Ingår i Bone Marrow Transplantation, 2017

• DOI för Inflammatory immune response after autologous transplantation in neurologic diseases

Epilepsy in multiple sclerosis: A nationwide population-based register study.

Burman, Joachim; Zelano, Johan

Ingår i Neurology, s. 2462-2468, 2017

• DOI för Epilepsy in multiple sclerosis: A nationwide population-based register study.

Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought

Burman, Joachim; Fox, Robert J.

Ingår i Neurology, s. 2072-2073, 2017

• DOI för Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Johansson, S.; Forsberg, L.; Hillert, J.; Nilsson, P. et al.

Ingår i Multiple Sclerosis Journal, s. 336-337, 2016

Rituximab in multiple sclerosis; data from the swedish MS registry.

Alping, P.; Svenningsson, A.; Salzer, J.; Burman, Joachim et al.

Ingår i Multiple Sclerosis Journal, s. 49-49, 2016

Real world experience of fingolimod after switching multiple sclerosis (MS) therapy; focus on natalizumab naive and experienced persons with MS, respectively

Forsberg, L.; Johansson, S.; Frisell, T.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 647-648, 2016

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)

Forsberg, L.; Johansson, S.; Hillert, J.; Nilsson, P. et al.

Ingår i Multiple Sclerosis Journal, s. 338-339, 2016

Adverse events of rituximab in a Swedish MS population sample.

Bostrom, I.; Burman, Joachim; Landtblom, A-M

Ingår i Multiple Sclerosis Journal, s. 871-871, 2016

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

Burman, Joachim; Svenningsson, Anders

Ingår i Journal of Neuroimmunology, s. 40-44, 2016

• DOI för Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

Burman, Joachim; Raininko, Raili; Blennow, Kaj; Zetterberg, Henrik et al.

Ingår i Journal of Neuroimmunology, s. 52-57, 2016

• DOI för YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

The IMSE 2 study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of fingolimod

Johansson, S.; Forsberg, L.; Nordin, N.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 284-285, 2015

Severe relapses and rebound activity after natalizumab discontinuation in MS patients with more than five years of treatment with stable disease course

Fagius, Jan; Burman, Joachim; Feresiadou, Amalia; Larsson, Elna-Marie

Ingår i Multiple Sclerosis Journal, s. 297-297, 2015

A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of dimethyl fumarate

Forsberg, L.; Johansson, S.; Nordin, N.; Hillert, J. et al.

Ingår i Multiple Sclerosis Journal, s. 286-287, 2015

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab

Johansson, S.; Forsberg, L.; Hillert, J.; Nilsson, P. et al.

Ingår i Multiple Sclerosis Journal, s. 285-286, 2015

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

Greco, Raffaella; Bondanza, Attilio; Oliveira, Maria Carolina; Badoglio, Manuela et al.

Ingår i Multiple Sclerosis Journal, s. 189-197, 2015

• DOI för Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

Rystedt, Alma; Zetterberg, Lena; Burman, Joachim; Nyholm, Dag et al.

Ingår i Clinical neuropharmacology, s. 170-176, 2015

• DOI för A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis

Burt, Richard K; Balabanov, Roumen; Han, Xiaoqiang; Sharrack, Basil et al.

Ingår i Journal of the American Medical Association (JAMA), s. 275-284, 2015

• DOI för Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis

Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)

Snarski, E; Snowden, J A; Oliveira, M C; Simoes, B et al.

Ingår i Bone Marrow Transplantation, s. 216-220, 2015

• DOI för Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)

A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of natalizumab

Jonsson, L.; Holmen, C.; Hillert, J.; Nilsson, P. et al.

Ingår i Multiple Sclerosis Journal, s. 166-166, 2014

Intranasal Delivery of CNS-Retargeted Human Mesenchymal Stromal Cells Prolongs Treatment Efficacy of Experimental Autoimmune Encephalomyelitis

Fransson, Moa; Piras, Elena; Wang, Hao; Burman, Joachim et al.

Ingår i Immunology, s. 431-441, 2014

• DOI för Intranasal Delivery of CNS-Retargeted Human Mesenchymal Stromal Cells Prolongs Treatment Efficacy of Experimental Autoimmune Encephalomyelitis

Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis

Burman, Joachim; Svensson, Emma; Fransson, Moa; Loskog, Angelica et al.

Ingår i Journal of Neuroimmunology, s. 141-141, 2014

• DOI för Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis

Assessing tissue damage in multiple sclerosis: a biomarker approach

Burman, Joachim; Zetterberg, H; Fransson, Moa; Loskog, Angelica SI. et al.

Ingår i Acta Neurologica Scandinavica, s. 81-89, 2014

• DOI för Assessing tissue damage in multiple sclerosis: a biomarker approach

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Burman, Joachim; Svensson, Emma; Fransson, Moa; Loskog, Angelica S I et al.

Ingår i Journal of Neuroimmunology, s. 153-159, 2014

• DOI för The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Normal outcome of pregnancy with ongoing treatment with natalizumab

Fagius, Jan; Burman, Joachim

Ingår i Acta Neurologica Scandinavica, 2014

• DOI för Normal outcome of pregnancy with ongoing treatment with natalizumab

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Burman, Joachim; Iacobaeus, Ellen; Svenningsson, Anders; Lycke, Jan et al.

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 1116-1121, 2014

• DOI för Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

Burman, Joachim; Fransson, Moa; Tötterman, Thomas H.; Fagius, Jan et al.

Ingår i Immunology, s. 211-219, 2013

• DOI för T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Fransson, Moa; Piras, Elena; Burman, Joachim; Nilsson, Berith et al.

Ingår i Journal of Neuroinflammation, s. 112, 2012

• DOI för CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
• Ladda ner fulltext (pdf) av CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Svenska neurologföreningen: Antalet neurologer som behöver fördubblas under den kommande tioårsperioden

Remahl, Ingela Nilsson; Fredrikson, Sten; Gunnarsson, Martin; Hietala, Albert et al.

Ingår i Läkartidningen, s. 970-970, 2012

Autologous hematopoietic stem cell transplantation for multiple sclerosis: if confused or hesitant, remember 'Treat with standard immune suppressive drugs and if no inflammation, no response'

Burt, Richard K; Balabanov, Roumen; Voltarelli, Julio; Barreira, Amilton et al.

Ingår i Multiple Sclerosis Journal, s. 772-775, 2012

• DOI för Autologous hematopoietic stem cell transplantation for multiple sclerosis: if confused or hesitant, remember 'Treat with standard immune suppressive drugs and if no inflammation, no response'

Bilateral and recurrent optic neuritis in multiple sclerosis

Burman, Joachim; Raininko, Raili; Fagius, Jan

Ingår i Acta Neurologica Scandinavica, s. 207-210, 2011

• DOI för Bilateral and recurrent optic neuritis in multiple sclerosis

T regulatory cells lacking CD25 are increased in MS during relapse

Fransson, Moa; Burman, Joachim; Lindqvist, Camilla; Atterby, Christina et al.

Ingår i Autoimmunity, s. 590-597, 2010

• DOI för T regulatory cells lacking CD25 are increased in MS during relapse

New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis

Burt, Richard K.; Muraro, Paolo A.; Farge, Dominique; Oliveira, Maria Carolina et al.

Ingår i Bone Marrow Transplantation, s. 1509-1517, 2021

• DOI för New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis

Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Momtazmanesh, Sara; Shobeiri, Parnian; Saghazadeh, Amene; Teunissen, Charlotte E. et al.

Ingår i Reviews in the Neurosciences, s. 573-595, 2021

• DOI för Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis

Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Roberts, Fiona; Hobbs, Helen; Jessop, Helen; Bozzolini, Cristina et al.

Ingår i Frontiers in Neurology, 2020

• DOI för Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)
• Ladda ner fulltext (pdf) av Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Bridel, Claire; van Wieringen, Wessel N.; Zetterberg, Henrik; Tijms, Betty M. et al.

Ingår i JAMA Neurology, s. 1035-1048, 2019

• DOI för Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Autologous haematopoietic stem cell transplantation for neurological diseases

Burman, Joachim; Tolf, Andreas; Hägglund, Hans; Askmark, Håkan

Ingår i Journal of Neurology, Neurosurgery and Psychiatry, s. 147-155, 2018

• DOI för Autologous haematopoietic stem cell transplantation for neurological diseases
• Ladda ner fulltext (pdf) av Autologous haematopoietic stem cell transplantation for neurological diseases

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society

Vågberg, M; Axelsson, M; Birgander, R; Burman, Joachim et al.

Ingår i Acta Neurologica Scandinavica, s. 17-24, 2017

• DOI för Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
• Ladda ner fulltext (pdf) av Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society

Neurologi

Nyholm, Dag; Burman, Joachim

Liber, 2020

Curing Multiple Sclerosis: How to do it and how to prove it

Burman, Joachim

2014

• Ladda ner fulltext (pdf) av Curing Multiple Sclerosis: How to do it and how to prove it

Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders

Kirgizov, Kirill; Burman, Joachim; Snowden, John A.; Greco, Raffaella

Ingår i Handbook of Clinical Neurology, s. 249-258, Elsevier, 2024

• DOI för Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders

Den neurologiska konsultationen

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Neurologisk symtomlära

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Engineered T regulatory cells target CNS and suppress active EAE upon intra nasal delivery

Fransson, Moa; Piras, E; Wang, H; Burman, Joachim et al.

Human Mesenchymal stromal cells expressing a CNS-targeting receptor can be administrated intra nasally and cure expersimental autoimmune enchphlomyelitis

Fransson, Moa; Piras, E; Wang, H; Burman, Joachim et al.

A biochemical signature of progressive multiple sclerosis

Herman, Stephanie; Emami Khoonsari, Payam; Bergman, Joakim; Svenningsson, Anders et al.

Biological markers for CNS damage in a patient cohort with suspected autoimmune psychiatric disease

Syk, Mikaela; Malmström, Emma; Gallwitz, Maike; Fällmar, David et al.

Cerebral blood flow in multiple sclerosis: an ¹⁵O-water PET study

Tolf, Andreas; Hedman, Karolina; Appel, Lieuwe; Larsson, Elna-Marie et al.